Greg Stone

906 total citations
7 papers, 708 citations indexed

About

Greg Stone is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Greg Stone has authored 7 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Molecular Medicine and 2 papers in Infectious Diseases. Recurrent topics in Greg Stone's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Antibiotic Use and Resistance (2 papers). Greg Stone is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Antibiotic Use and Resistance (2 papers). Greg Stone collaborates with scholars based in United States, United Kingdom and Czechia. Greg Stone's co-authors include J. Armstrong, Paul Newell, Leanne B. Gasink, Angela Wardman, Peter J. Laud, Yehuda Carmeli, Helen Broadhurst, Lily Llorens, John E. Mazuski and Jan Pachl and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Medicinal Chemistry and The Lancet Infectious Diseases.

In The Last Decade

Greg Stone

7 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Greg Stone United States	6	531	408	274	247	82	7	708
Konstantinos Pontikis Greece	8	582 1.1×	435 1.1×	342 1.2×	146 0.6×	60 0.7×	21	742
Jiejun Du United States	10	500 0.9×	390 1.0×	275 1.0×	264 1.1×	74 0.9×	22	748
Irene Gracia-Ahufinger Spain	14	402 0.8×	195 0.5×	273 1.0×	171 0.7×	73 0.9×	29	588
Martha Nepka Greece	4	449 0.8×	281 0.7×	172 0.6×	150 0.6×	106 1.3×	6	522
G. Poulakou Greece	8	616 1.2×	427 1.0×	350 1.3×	123 0.5×	49 0.6×	10	781
Athina Argyrοpoulou Greece	9	508 1.0×	325 0.8×	248 0.9×	212 0.9×	128 1.6×	15	725
Georgios L. Voulgaris Greece	9	315 0.6×	293 0.7×	253 0.9×	113 0.5×	49 0.6×	10	561
Patrick McLeroth United States	8	331 0.6×	239 0.6×	195 0.7×	150 0.6×	100 1.2×	12	554
Rachel V Marini United States	8	407 0.8×	325 0.8×	242 0.9×	183 0.7×	78 1.0×	16	588
Ana Maria Sandri Brazil	10	410 0.8×	340 0.8×	259 0.9×	68 0.3×	64 0.8×	11	613

Countries citing papers authored by Greg Stone

Since Specialization

Citations

This map shows the geographic impact of Greg Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Stone more than expected).

Fields of papers citing papers by Greg Stone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Stone. The network helps show where Greg Stone may publish in the future.

Co-authorship network of co-authors of Greg Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Stone. A scholar is included among the top collaborators of Greg Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Stone. Greg Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Kazmierczak, Krystyna M., et al.. (2020). 1580. In Vitro Activity of Ceftazidime-Avibactam Against Enterobacterales and Pseudomonas aeruginosa Collected in Latin America as part of the ATLAS Global Surveillance Program, 2017-2019. Open Forum Infectious Diseases. 7(Supplement_1). S788–S788. 1 indexed citations

Carmeli, Yehuda, J. Armstrong, Peter J. Laud, et al.. (2016). Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. The Lancet Infectious Diseases. 16(6). 661–673. 319 indexed citations

Mazuski, John E., Leanne B. Gasink, J. Armstrong, et al.. (2016). Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program. Clinical Infectious Diseases. 62(11). 1380–1389. 287 indexed citations

Akritopoulou‐Zanze, Irini, Zhenkun Ma, Greg Stone, et al.. (2004). Synthesis and antibacterial activity of novel bifunctional macrolides. Bioorganic & Medicinal Chemistry Letters. 14(14). 3809–3813. 9 indexed citations

Keyes, Robert F., et al.. (2003). Synthesis and Antibacterial Activity of 6-O-Arylbutynyl Ketolides with Improved Activity against Some Key Erythromycin-Resistant Pathogens. Journal of Medicinal Chemistry. 46(10). 1795–1798. 41 indexed citations

Cesario, Thomas C., et al.. (2000). Nasal colonization by methicillin-resistant coagulase-negative Staphylococcus in community skilled nursing facility patients. American Journal of Infection Control. 28(3). 269–272. 22 indexed citations

Davidson, Harriet J., et al.. (1994). Conjunctival microbial flora of clinically normal pigs. American Journal of Veterinary Research. 55(7). 949–951. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact